ElevateBio, LLC - Jul 28, 2022 Form 4 Insider Report for Allovir, Inc. (ALVR)

Role: Director, 10%+ Owner
Signature: ELEVATEBIO, LLC, By: /s/ Jake Abrams
Stock symbol: ALVR
Transactions as of: Jul 28, 2022
Transactions value $: $15,000,000
Form type: 4
Date filed: 8/1/2022, 04:35 PM

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ALVR	Common Stock	Award	$15M	+3.25M	+24.24%	$4.61	16.7M	Jul 28, 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On July 28, 2022, ElevateBio LLC ("ElevateBio") acquired 3,253,796 shares of the Issuer's Common Stock in a registered direct offering at a price of $4.61 per share.
F2	These shares are directly held by ElevateBio. David Hallal, Vikas Sinha, Morana Jovan-Embiricos and Ansbert Gadicke are directors of ElevateBio, and may be deemed to have shared voting and investment power of the shares held by ElevateBio. Such persons disclaim beneficial ownership of all shares held by ElevateBio except to the extent of their pecuniary interest therein, if any.

Remarks:

David Hallal, Vikas Sinha, Morana Jovan-Embiricos and Ansbert Gadiske are directors of ElevateBio, and each serve on the board of directors of the Issuer. By virtue of their representation, for purposes of Section 16 of the Securities Exchange Act of 1934 (the "Exchange Act"), the Reporting Person may be deemed a director by deputization of the Issuer. This filing shall not be deemed an admission that the Reporting Person is a beneficial owner of the securities reported in this filing for purposes of Section 16 of the Exchange Act or otherwise, or is subject to Section 16 of the Exchange Act, and the Reporting Person disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein, if any.